| Literature DB >> 27293516 |
Heba M Abdou1, Mayssaa M Wahby2.
Abstract
Triton WR-1339 administration causes neurotoxicity. Natural products and herbal extracts can attenuate cerebral injury. In the present study, we investigated the neuroprotective role of grape seed extract and/or vitamin B6 against triton-induced neurotoxicity. Thirty-five adult male albino rats of the Sprague-Dawley strain, weighing 140-145 g, were divided into five groups: control, triton, grape seed extract + triton, grape seed extract + triton + vitamin B6, and vitamin B6 + triton. The hematological and biochemical analyses were carried out. Alteration in iNOS mRNA gene expression was determined using reverse-transcriptase PCR analysis. In addition, qualitative DNA fragmentation was examined using agarose gel electrophoresis. Triton-treatment caused significant disturbances in the hematological parameters, the neurological functions, and the antioxidant profile. Also, triton significantly increased the iNOS mRNA expression and DNA damage. Our results showed that grape seed extract and/or vitamin B6 could attenuate all the examined parameters. These natural substances could exhibit protective effects against triton-induced neurological damage because of their antioxidative and antiapoptotic capacities.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27293516 PMCID: PMC4884861 DOI: 10.1155/2016/8679506
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Changes in the hematological parameters in the blood samples of the different experimental groups.
| Source | Parameters | Experimental groups | ||||
|---|---|---|---|---|---|---|
| Control | Triton | GSE + triton | GSE + triton + B6 | B6 + triton | ||
| Blood | HB | 12.68 ± 0.22 | 6.74a ± 0.28 | 10.42ab ± 0.14 | 11.66ab ± 0.07 | 9.84ab ± 0.093 |
| −46.8% | −17.9% | −8% | −22% | |||
| PCV | 37.99 ± 0.59 | 22.06a ± 0.41 | 32.71ab ± 0.50 | 35.61ab ± 0.22 | 28.48ab ± 0.51 | |
| −41.9% | −13.9% | −6% | −25% | |||
| TEC | 4.70 ± 0.095 | 2.58a ± 0.06 | 3.80ab ± 0.05 | 4.22ab ± 0.12 | 3.06ab ± 0.07 | |
| −45% | −19% | −10% | −34.9% | |||
| TLC | 8.20 ± 0.09 | 4.94a ± 0.07 | 5.90ab ± 0.095 | 8.12b ± 0.10 | 6.56ab ± 0.17 | |
| −39.7% | −28% | −0.97% | −20% | |||
| PLT | 309.60 ± 0.51 | 552.40a ± 1.36 | 299.60ab ± 2.23 | 309.00b ± 0.55 | 283.00ab ± 3.21 | |
| 78.4% | −3% | −0.19% | −8.6% | |||
Values are expressed as means ± SE.
aThe mean values are significantly different in comparison with the control group at p ≤ 0.05.
bThe mean values are significantly different in comparison with the triton-intoxicated group at p ≤ 0.05.
Hb: hemoglobin (g/dL); PCV: packed cells volume (%); TEC: erythrocyte count (×1012 L−1); TLC: total leukocyte counts (×109 L−1); PLT: platelets (×1012 L−1).
Changes in the levels of serotonin, GSH, and MDA and the activities of AchE, GPX, SOD, CAT, and LDH in brain extract of different experimental groups.
| Parameters | Experimental groups | ||||
|---|---|---|---|---|---|
| Control | Triton | GSE + triton | GSE + triton + B6 | B6 + triton | |
| AchEA | 21.34 ± 0.33 | 35.38a ± 0.22 | 22.91ab ± 0.21 | 21.28b ± 0.39 | 23.90ab ± 0.28 |
| 65.8% | 7% | −0.28% | 12% | ||
|
| |||||
| SerotoninB | 350.70 ± 0.61 | 132.56a ± 0.26 | 280.88ab ± 2.23 | 252.52ab ± 0.40 | 232.22ab ± 0.33 |
| −62% | −20% | −28% | −33.8% | ||
|
| |||||
| GSHC | 50.26 ± 0.24 | 23.84a ± 0.38 | 42.14ab ± 0.17 | 49.76b ± 0.14 | 43.23ab ± 0.17 |
| −52.6% | −16% | −1% | −14% | ||
|
| |||||
| GPXD | 53.99 ± 0.18 | 19.24a ± 0.29 | 41.08ab ± 0.27 | 56.08ab ± 0.27 | 45.85ab ± 0.28 |
| −64% | −24% | 3.9% | −15% | ||
|
| |||||
| SODD | 65.64 ± 0.28 | 26.75a ± 0.13 | 51.08ab ± 0.26 | 60.16ab ± 0.32 | 52.60ab ± 0.25 |
| −59% | −22% | −0.1% | −20% | ||
|
| |||||
| CATD | 60.55 ± 0.26 | 16.14a ± 0.41 | 52.90ab ± 0.19 | 58.15ab ± 0.35 | 47.63ab ± 0.37 |
| −89.9% | −12.6% | −4% | −21% | ||
|
| |||||
| MDAE | 24.84 ± 0.11 | 76.24a ± 0.21 | 34.60ab ± 0.39 | 28.44ab ± 0.25 | 36.86ab ± 0.17 |
| 206.9% | 39% | 14% | 48% | ||
|
| |||||
| LDHF | 113.20 ± 0.42 | 37.69a ± 0.30 | 95.94ab ± 0.11 | 101.46ab ± 0.15 | 93.44ab ± 0.28 |
| −66.7% | −15% | −10% | −17% | ||
Values are expressed as means ± SE.
aThe mean values are significantly different in comparison with the control group at p ≤ 0.01.
bThe mean values are significantly different in comparison with the triton-intoxicated group at p ≤ 0.01.
A: μmol substrate hydrolyzed/min/mg protein, B: ng/g tissue, C: μmol/g tissue, D: U/mg protein, E: nmol/g tissue, and F: mg/g tissue.
Figure 1Reverse-transcriptase PCR (RT-PCR) analysis of iNOS mRNA expression in the different experimental groups.
Figure 2iNOS mRNA expression in the different experimental groups relative to β actin level as internal control. p < 0.001 calculated with reference to control sample.
Figure 3Detection of brain DNA fragmentation on agarose gel electrophoresis of the different experimental groups. The first lane, control; the second lane, triton-treated rats; the third lane, GSE + triton-treated rats; the fourth lane, the GSE + triton + B6-treated rats; the fifth lane, B6 + triton-treated rats.